SRC
SNY icon

Sage Rhino Capital’s Sanofi SNY Stock Holding History

Sage Rhino Capital’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Sell
7,084
-1,106
-14% -$49.4K 0.05% 223
2026
Q1 		$395K Sell
8,190
-4
-0% -$187 0.07% 164
2025
Q4 		$397K Sell
8,194
-122
-1% -$6.05K 0.08% 162
2025
Q3 		$393K Sell
8,316
-103
-1% -$4.97K 0.08% 156
2025
Q2 		$407K Sell
8,419
-229
-3% -$11.7K 0.09% 147
2025
Q1 		$480K Buy
8,648
+26
+0.3% +$1.41K 0.11% 139
2024
Q4 		$416K Buy
8,622
+47
+0.5% +$2.39K 0.09% 147
2024
Q3 		$494K Buy
8,575
+149
+2% +$8.04K 0.11% 137
2024
Q2 		$409K Buy
8,426
+59
+0.7% +$2.85K 0.1% 142
2024
Q1 		$407K Buy
8,367
+161
+2% +$7.86K 0.1% 145
2023
Q4 		$408K Sell
8,206
-516
-6% -$25.2K 0.1% 136
2023
Q3 		$468K Buy
8,722
+240
+3% +$12.8K 0.13% 121
2023
Q2 		$457K Sell
8,482
-87
-1% -$4.68K 0.13% 124
2023
Q1 		$466K Buy
8,569
+647
+8% +$31.5K 0.14% 120
2022
Q4 		$384K Buy
7,922
+830
+12% +$36.4K 0.12% 131
2022
Q3 		$270K Sell
7,092
-616
-8% -$27.4K 0.11% 142
2022
Q2 		$386K Buy
7,708
+207
+3% +$11K 0.15% 114
2022
Q1 		$385K Buy
7,501
+3
+0% +$155 0.12% 145
2021
Q4 		$376K Sell
7,498
-58
-0.8% -$2.87K 0.11% 140
2021
Q3 		$364K Buy
7,556
+374
+5% +$19K 0.11% 131
2021
Q2 		$378K Buy
7,182
+611
+9% +$31.9K 0.11% 135
2021
Q1 		$325K Buy
6,571
+61
+0.9% +$2.93K 0.11% 131
2020
Q4 		$316K Buy
6,510
+135
+2% +$6.66K 0.12% 121
2020
Q3 		$320K Hold
6,375
– – 0.15% 108
2020
Q2 		$325K Buy
6,375
+27
+0.4% +$1.31K 0.17% 105
2020
Q1 		$278K Buy
6,348
+331
+6% +$15.8K 0.2% 95
2019
Q4 		$311K Buy
6,017
+409
+7% +$19.2K 0.18% 112
2019
Q3 		$260K Buy
5,608
+243
+5% +$10.5K 0.16% 111
2019
Q2 		$232K Buy
5,365
+360
+7% +$15.3K 0.15% 116
2019
Q1 		$222K Buy
+5,005
New +$214K 0.15% 115

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Sage Rhino Capital's SNY Position: Q2 2026 in Review

Sage Rhino Capital reduced its Sanofi (SNY) stake by 14% in Q2 2026, selling an estimated $49.4K and leaving 7,084 shares worth $302K. The position accounts for 0.05% of the portfolio, ranked #223.

Sage Rhino Capital first reported a position in SNY in Q1 2019 and has held it in 30 quarters since. The position peaked at $494K in Q3 2024. 718 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Sage Rhino Capital held 7,084 shares of Sanofi worth $302K as of Q2 2026.
  • Sage Rhino Capital sold 1,106 Sanofi shares in Q2 2026, an estimated $49.4K.
  • Sanofi made up 0.05% of Sage Rhino Capital's portfolio in Q2 2026, its #223 holding.
  • Sage Rhino Capital first reported a position in Sanofi in Q1 2019 and has held it in 30 quarters since.
  • Sage Rhino Capital's Sanofi position peaked at $494K in Q3 2024.
  • 718 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Sage Rhino Capital's 13F filing for Q2 2026, filed 3 Aug 2026.